Statistics
Publications
30
Citations
3K
H-Index
22
Active since
2011
Jaebong Jang is an author at Dana-Farber Cancer Institute specializing in drug discovery, medicinal chemistry, and pharmacology.
Publications per year
2011–2023
30
30
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia, Cai‐Hong Yun, Eunyoung Park et al. · Nature · 2016 · 879 citations · Full text
Medicine, Oncology, Pharmacology +11
Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
Ciric To, Jaebong Jang, Ting Chen et al. · Cancer Discovery · 2019 · 331 citations · Full text
Medicine, Oncology, Pharmacology +15
Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 161 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 30